XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Cash Flows (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash Flows from Operating Activities:    
Net income $ 9,230us-gaap_ProfitLoss $ 8,816us-gaap_ProfitLoss
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,665us-gaap_DepreciationAndAmortization 2,887us-gaap_DepreciationAndAmortization
Provision for bad debts 10,784FONR_ProvisionForBadDebts 7,894FONR_ProvisionForBadDebts
Non-cash considerations 76FONR_NoncashConsiderations 407FONR_NoncashConsiderations
Stock option exercised    31us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants
Compensatory element of stock issuances 53us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan 86us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan
(Increase) decrease in operating assets, net:    
Accounts, management fee and medical receivable(s) (13,554)us-gaap_IncreaseDecreaseInAccountsReceivable (11,012)us-gaap_IncreaseDecreaseInAccountsReceivable
Notes receivable 118us-gaap_IncreaseDecreaseInReceivables 75us-gaap_IncreaseDecreaseInReceivables
Costs and estimated earnings in excess of billings on uncompleted contracts 79us-gaap_IncreaseDecreaseInUnbilledReceivables (236)us-gaap_IncreaseDecreaseInUnbilledReceivables
Inventories 158us-gaap_IncreaseDecreaseInInventories (433)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets 89us-gaap_IncreaseDecreaseInPrepaidExpense 31us-gaap_IncreaseDecreaseInPrepaidExpense
Other assets 18us-gaap_IncreaseDecreaseInOtherNoncurrentAssets 63us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Increase (decrease) in operating liabilities, net:    
Accounts payable (178)us-gaap_IncreaseDecreaseInAccountsPayable 110us-gaap_IncreaseDecreaseInAccountsPayable
Other current liabilities (501)us-gaap_IncreaseDecreaseInOtherCurrentLiabilities 964us-gaap_IncreaseDecreaseInOtherCurrentLiabilities
Customer advances (259)us-gaap_IncreaseDecreaseInCustomerAdvances (67)us-gaap_IncreaseDecreaseInCustomerAdvances
Other liabilities (230)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities (221)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities
Due to related medical practices (2)us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties 1us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties
Income tax payable    (20)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable
Net cash provided by operating activities 8,546us-gaap_NetCashProvidedByUsedInOperatingActivities 9,376us-gaap_NetCashProvidedByUsedInOperatingActivities
Cash Flows from Investing Activities:    
Purchases of property and equipment (125)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (375)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Cost of patents (108)us-gaap_PaymentsToAcquireIntangibleAssets (172)us-gaap_PaymentsToAcquireIntangibleAssets
Net cash used in investing activities (233)us-gaap_NetCashProvidedByUsedInInvestingActivities (547)us-gaap_NetCashProvidedByUsedInInvestingActivities
Cash Flows from Financing Activities:    
Repayment of borrowings and capital lease obligations (2,166)us-gaap_RepaymentsOfNotesPayable (3,401)us-gaap_RepaymentsOfNotesPayable
Distributions to noncontrolling interests (3,306)us-gaap_PaymentsOfDividendsMinorityInterest (3,724)us-gaap_PaymentsOfDividendsMinorityInterest
Buyout of noncontrolling interests (4,971)FONR_BuyoutOfNoncontrollingInterests   
Repayment of notes receivable from employee stockholders 6us-gaap_RepaymentsOfOtherDebt 14us-gaap_RepaymentsOfOtherDebt
Net cash used in financing activities (10,437)us-gaap_NetCashProvidedByUsedInFinancingActivities (7,111)us-gaap_NetCashProvidedByUsedInFinancingActivities
Net (Decrease) Increase in Cash and Cash Equivalents (2,124)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 1,718us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and Cash Equivalents - Beginning of Period 9,952us-gaap_CashAndCashEquivalentsAtCarryingValue 7,871us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and Cash Equivalents - End of Period $ 7,828us-gaap_CashAndCashEquivalentsAtCarryingValue $ 9,589us-gaap_CashAndCashEquivalentsAtCarryingValue